Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Symptoms of Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: A Prospective Cohort Study.

Levy AR, Xing S, Brunelli SM, Cooper K, Finkelstein FO, Germain MJ, Kimel M, Platt RW, Belozeroff V.

Am J Kidney Dis. 2019 Oct 16. pii: S0272-6386(19)30942-4. doi: 10.1053/j.ajkd.2019.07.013. [Epub ahead of print]

PMID:
31629575
2.

The Impact of Anemia Treatment on Health-Related Quality of Life in Patients With Chronic Kidney Disease in the Contemporary Era.

Finkelstein FO, Finkelstein SH.

Adv Chronic Kidney Dis. 2019 Jul;26(4):250-252. doi: 10.1053/j.ackd.2019.04.003. Review.

PMID:
31477255
3.

Toward Developing a Patient-Reported Outcome Measure for Fatigue in Hemodialysis.

Nair D, Finkelstein FO.

Am J Kidney Dis. 2019 Aug;74(2):151-154. doi: 10.1053/j.ajkd.2019.03.425. Epub 2019 May 30. No abstract available.

PMID:
31155324
4.

Evaluation of one year of frequent dialysis on fluid load and body composition using calf bioimpedance technique.

Zhu F, Kaysen GA, Sarkar S, Finkelstein FO, Carter M, Levin NW, Hoenich NA.

Physiol Meas. 2019 Jun 4;40(5):055004. doi: 10.1088/1361-6579/ab1d8f.

PMID:
31035269
5.

Increasing access to integrated ESKD care as part of universal health coverage.

Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O'Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit.

Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005. Review.

6.

The Association of Functional Status with Mortality and Dialysis Modality Change: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).

Tennankore K, Zhao J, Karaboyas A, Bieber BA, Robinson BM, Morgenstern H, Jassal SV, Finkelstein FO, Kanjanabuch T, Cheawchanwattana A, Pisoni RL, Sloand JA, Perl J; PDOPPS patient support working group.

Perit Dial Int. 2019 Mar-Apr;39(2):103-111. doi: 10.3747/pdi.2018.00094. Epub 2019 Feb 9.

PMID:
30739094
7.

Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease.

Finkelstein FO, van Nooten F, Wiklund I, Trundell D, Cella D.

Health Qual Life Outcomes. 2018 May 31;16(1):111. doi: 10.1186/s12955-018-0933-8.

8.

Peritoneal Dialysis for AKI in Cameroon: Commercial vs Locally-Made Solutions.

Palmer D, Lawton WJ, Barrier C Jr, Fine BD Jr, Hemphill H, Nyah NN, Kinne V, Ringnwi NI, Yong G, Neufeldt AL, Mitterand Y, Finkelstein FO, Krahn TA.

Perit Dial Int. 2018 Jul-Aug;38(4):246-250. doi: 10.3747/pdi.2017.00190. Epub 2018 May 23.

PMID:
29793982
9.

Peritoneal Dialysis in Austere Environments: An Emergent Approach to Renal Failure Management.

Gorbatkin C, Bass J, Finkelstein FO, Gorbatkin SM.

West J Emerg Med. 2018 May;19(3):548-556. doi: 10.5811/westjem.2018.3.36762. Epub 2018 Apr 5. Review.

10.

Assessing Fatigue in the ESRD Patient: A Step Forward.

Finkelstein FO, Finkelstein SH.

Am J Kidney Dis. 2018 Mar;71(3):306-308. doi: 10.1053/j.ajkd.2017.10.021. No abstract available.

PMID:
29477175
11.

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease.

Ermer T, Kopp C, Asplin JR, Granja I, Perazella MA, Reichel M, Nolin TD, Eckardt KU, Aronson PS, Finkelstein FO, Knauf F.

Kidney Int Rep. 2017 Jun 8;2(6):1050-1058. doi: 10.1016/j.ekir.2017.06.002. eCollection 2017 Nov.

12.

Time to Rethink Our Approach to Patient-Reported Outcome Measures for ESRD.

Finkelstein FO, Finkelstein SH.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1885-1888. doi: 10.2215/CJN.04850517. Epub 2017 Aug 28. No abstract available.

13.

Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update.

Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, Lambie M, de Moraes TP, Morelle J, Woodrow G.

Perit Dial Int. 2017 Jul-Aug;37(4):362-374. doi: 10.3747/pdi.2017.00018. Review. No abstract available.

PMID:
28676507
14.

Tryptophan and Kynurenine Levels and Its Association With Sleep, Nonphysical Fatigue, and Depression in Chronic Hemodialysis Patients.

Malhotra R, Persic V, Zhang W, Brown J, Tao X, Rosales L, Thijssen S, Finkelstein FO, Unruh ML, Ikizler A, Garimella PS, Ix JH, Kooman J, Levin NW, Handelman GJ, Kotanko P.

J Ren Nutr. 2017 Jul;27(4):260-266. doi: 10.1053/j.jrn.2017.01.024. Epub 2017 Mar 30.

PMID:
28366444
15.

Peritoneal Dialysis to Treat Patients with Acute Kidney Injury-The Saving Young Lives Experience in West Africa: Proceedings of the Saving Young Lives Session at the First International Conference of Dialysis in West Africa, Dakar, Senegal, December 2015.

Abdou N, Antwi S, Koffi LA, Lalya F, Adabayeri VM, Nyah N, Palmer D, Brusselmans A, Cullis B, Feehally J, McCulloch M, Smoyer W, Finkelstein FO.

Perit Dial Int. 2017 Mar-Apr;37(2):155-158. doi: 10.3747/pdi.2016.00178. Review.

PMID:
28360366
16.

Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.

Bagshaw SM, Darmon M, Ostermann M, Finkelstein FO, Wald R, Tolwani AJ, Goldstein SL, Gattas DJ, Uchino S, Hoste EA, Gaudry S.

Intensive Care Med. 2017 Jun;43(6):841-854. doi: 10.1007/s00134-017-4762-8. Epub 2017 Mar 13. Review.

PMID:
28289816
17.

Symptom Management of the Patient with CKD: The Role of Dialysis.

Cabrera VJ, Hansson J, Kliger AS, Finkelstein FO.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):687-693. doi: 10.2215/CJN.01650216. Epub 2017 Feb 1. Review.

18.

Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.

Garg AX, Suri RS, Eggers P, Finkelstein FO, Greene T, Kimmel PL, Kliger AS, Larive B, Lindsay RM, Pierratos A, Unruh M, Chertow GM; Frequent Hemodialysis Network Trial Investigators.

Kidney Int. 2017 Mar;91(3):746-754. doi: 10.1016/j.kint.2016.10.033. Epub 2017 Jan 13.

19.

Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology.

Feehally J, Brusselmans A, Finkelstein FO, Harden P, Harris D, Manuzi G, Naicker S, Tonelli M, Cameron H.

Kidney Int Suppl (2011). 2016 Dec;6(2):42-51. doi: 10.1016/j.kisu.2016.09.002. Epub 2016 Nov 21.

20.

Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils?

Brown EA, Finkelstein FO, Iyasere OU, Kliger AS.

Kidney Int. 2017 Feb;91(2):294-303. doi: 10.1016/j.kint.2016.08.026. Epub 2016 Oct 20. Review.

PMID:
27773426
21.

Intensive Hemodialysis and Health-Related Quality of Life.

Kraus MA, Fluck RJ, Weinhandl ED, Kansal S, Copland M, Komenda P, Finkelstein FO.

Am J Kidney Dis. 2016 Nov;68(5S1):S33-S42. doi: 10.1053/j.ajkd.2016.05.023. Review.

PMID:
27772641
22.

Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.

Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner HC, Vanholder RC, Combe C, Hasegawa T, Finkelstein FO, Lopes AA, Robinson BM, Pisoni RL, Tentori F.

Nephrol Dial Transplant. 2017 Mar 1;32(3):521-527. doi: 10.1093/ndt/gfw233.

23.

The effect of frequent hemodialysis on self-reported sleep quality: Frequent Hemodialysis Network Trials.

Unruh ML, Larive B, Eggers PW, Garg AX, Gassman JJ, Finkelstein FO, Kimmel PL, Chertow GM; FHN Trial Group.

Nephrol Dial Transplant. 2016 Jun;31(6):984-91. doi: 10.1093/ndt/gfw062. Epub 2016 Apr 15.

24.

We Use Bioincompatible Peritoneal Dialysis Solutions.

Troidle L, Hansson J, Juergensen P, Finkelstein FO.

Semin Dial. 2016 Jul;29(4):263-4. doi: 10.1111/sdi.12490. Epub 2016 Apr 8.

PMID:
27061506
25.

Acute Kidney Injury in Low-Resource Settings: Barriers to Diagnosis, Awareness, and Treatment and Strategies to Overcome These Barriers.

Lunyera J, Kilonzo K, Lewington A, Yeates K, Finkelstein FO.

Am J Kidney Dis. 2016 Jun;67(6):834-40. doi: 10.1053/j.ajkd.2015.12.018. Epub 2016 Jan 29.

PMID:
26830256
26.

"Saving Young Lives" with acute kidney injury: the challenge of acute dialysis in low-resource settings.

Smoyer WE, Finkelstein FO, McCulloch MI, Carter M, Brusselmans A, Feehally J.

Kidney Int. 2016 Feb;89(2):254-6. doi: 10.1016/j.kint.2015.10.009. No abstract available.

PMID:
26806823
27.

Saving Young Lives: provision of acute dialysis in low-resource settings.

Smoyer WE, Finkelstein FO, McCulloch M, Carter M, Brusselmans A, Feehally J.

Lancet. 2015 Nov 21;386(10008):2056. doi: 10.1016/S0140-6736(15)00971-X. Epub 2015 Nov 20. No abstract available.

PMID:
26700390
28.

Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort.

Han SW, Tilea A, Gillespie BW, Finkelstein FO, Kiser MA, Eisele G, Kotanko P, Levin N, Saran R.

Am J Nephrol. 2015;41(3):200-9. doi: 10.1159/000381193. Epub 2015 Apr 8.

PMID:
25871915
29.

Impact of baseline health-related quality of life scores on survival of incident patients on peritoneal dialysis: a cohort study.

Grincenkov FR, Fernandes N, Pereira Bdos S, Bastos K, Lopes AA, Finkelstein FO, Pecoits-Filho R, Qureshi AR, Divino-Filho JC, Bastos MG.

Nephron. 2015;129(2):97-103. doi: 10.1159/000369139. Epub 2015 Jan 28.

PMID:
25633060
30.

Understanding acute kidney injury in low resource settings: a step forward.

Anand S, Cruz DN, Finkelstein FO.

BMC Nephrol. 2015 Jan 16;16:5. doi: 10.1186/1471-2369-16-5.

31.

Dialysis: is it realistic to compare peritoneal dialysis and haemodialysis?

Finkelstein FO, Levin NW.

Nat Rev Nephrol. 2014 Nov;10(11):618-9. doi: 10.1038/nrneph.2014.176. Epub 2014 Sep 30. No abstract available.

PMID:
25266213
32.

Performance measures in dialysis facilities: what is the goal?

Finkelstein FO.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):156-8. doi: 10.2215/CJN.04780514. Epub 2014 Sep 4.

33.

Peritoneal dialysis for acute kidney injury.

Cullis B, Abdelraheem M, Abrahams G, Balbi A, Cruz DN, Frishberg Y, Koch V, McCulloch M, Numanoglu A, Nourse P, Pecoits-Filho R, Ponce D, Warady B, Yeates K, Finkelstein FO.

Perit Dial Int. 2014 Jul-Aug;34(5):494-517. doi: 10.3747/pdi.2013.00222. Review. No abstract available.

34.

Peritoneal dialysis, acute kidney injury, and the Saving Young Lives program.

Finkelstein FO, Smoyer WE, Carter M, Brusselmans A, Feehally J.

Perit Dial Int. 2014 Jul-Aug;34(5):478-80. doi: 10.3747/pdi.2014.00041. No abstract available.

35.

First-year outcomes of incident peritoneal dialysis patients in the United States.

Pulliam J, Li NC, Maddux F, Hakim R, Finkelstein FO, Lacson E Jr.

Am J Kidney Dis. 2014 Nov;64(5):761-9. doi: 10.1053/j.ajkd.2014.04.025. Epub 2014 Jun 11.

PMID:
24927898
36.

Sexual Inactivity among hemodialysis patients: the patients' perspective.

Finkelstein FO, Finkelstein SH.

Clin J Am Soc Nephrol. 2014 Jan;9(1):6-7. doi: 10.2215/CJN.11831113. Epub 2013 Dec 19. No abstract available.

37.

The experience of dialysis therapy among younger adults.

Yalamanchili HB, Murray P, Awuah KT, Harden P, Finkelstein SH, Finkelstein FO.

Adv Perit Dial. 2013;29:46-9.

PMID:
24344491
38.

Patients initiating peritoneal dialysis started on two icodextrin exchanges daily.

Awuah KT, Gorban-Brennan N, Yalamanchili HB, Finkelstein FO.

Adv Perit Dial. 2013;29:1-3.

PMID:
24344481
39.

Longitudinal changes in health-related quality of life scores in Brazilian incident peritoneal dialysis patients (BRAZPD): socio-economic status not a barrier.

dos Santos Grincenkov FR, Fernandes N, Chaoubah A, da Silva Fernandes N, Bastos K, Lopes AA, Qureshi AR, Finkelstein FO, Pecoits-Filho R, Divino-Filho JC, Bastos MG.

Perit Dial Int. 2013 Nov-Dec;33(6):687-96. doi: 10.3747/pdi.2012.00038.

40.

Time to recovery after a hemodialysis session: impact of selected variables.

Awuah KT, Afolalu BA, Hussein UT, Raducu RR, Bekui AM, Finkelstein FO.

Clin Kidney J. 2013 Dec;6(6):595-8. doi: 10.1093/ckj/sft120. Epub 2013 Sep 29.

41.

How do we operationalize the individualization of ESA dosing and target Hb levels?

Finkelstein FO.

Nephrol News Issues. 2013 Jun;27(7):Supp 17-8. No abstract available.

PMID:
23855146
42.

Use of peritoneal dialysis in AKI: a systematic review.

Chionh CY, Soni SS, Finkelstein FO, Ronco C, Cruz DN.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1649-60. doi: 10.2215/CJN.01540213. Epub 2013 Jul 5. Review.

43.

Kidney failure: aims for the next 10 years and barriers to success.

Remuzzi G, Benigni A, Finkelstein FO, Grunfeld JP, Joly D, Katz I, Liu ZH, Miyata T, Perico N, Rodriguez-Iturbe B, Antiga L, Schaefer F, Schieppati A, Schrier RW, Tonelli M.

Lancet. 2013 Jul 27;382(9889):353-62. doi: 10.1016/S0140-6736(13)60438-9. Epub 2013 May 31. Review.

PMID:
23727164
44.

Quality of life of chronic kidney disease patients in developing countries.

Awuah KT, Finkelstein SH, Finkelstein FO.

Kidney Int Suppl (2011). 2013 May;3(2):227-229.

45.

Patient perceptions and experiences of ESRD care: quality and satisfaction.

Finkelstein FO, Yalamanchili HB, Kliger AS.

Am J Kidney Dis. 2013 Mar;61(3):366-7. doi: 10.1053/j.ajkd.2012.12.011. No abstract available.

PMID:
23414729
46.

Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.

Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Gassman J, Tarallo M, Finkelstein FO, Kimmel PL; FHN Trials Group.

Am J Kidney Dis. 2013 May;61(5):748-58. doi: 10.1053/j.ajkd.2012.11.047. Epub 2013 Jan 15.

47.

Peritoneal dialysis in patients 75 years of age and older--a 22-year experience.

Taveras AE, Bekui AM, Gorban-Brennan N, Raducu R, Finkelstein FO.

Adv Perit Dial. 2012;28:84-8.

PMID:
23311220
48.

Assessing and improving the health-related quality of life of patients with ESRD.

Finkelstein FO, Arsenault KL, Taveras A, Awuah K, Finkelstein SH.

Nat Rev Nephrol. 2012 Dec;8(12):718-24. doi: 10.1038/nrneph.2012.238. Epub 2012 Oct 23. Review.

PMID:
23090446
49.

Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis.

Warnock DG, Hebbar S, Bargman J, Burkart J, Davies S, Finkelstein FO, Mehrotra R, Ronco C, Teitelbaum I, Urakpo K, Chertow GM.

Contrib Nephrol. 2012;178:157-163. doi: 10.1159/000337837. Epub 2012 May 25. Review.

PMID:
22652731
50.

Acute kidney injury: are we biased against peritoneal dialysis?

Gaião S, Finkelstein FO, de Cal M, Ronco C, Cruz DN.

Perit Dial Int. 2012 May-Jun;32(3):351-5. doi: 10.3747/pdi.2010.00227. No abstract available.

Supplemental Content

Loading ...
Support Center